267 related articles for article (PubMed ID: 33619557)
21. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
Revilla-I-Domingo R; Bilic I; Vilagos B; Tagoh H; Ebert A; Tamir IM; Smeenk L; Trupke J; Sommer A; Jaritz M; Busslinger M
EMBO J; 2012 Jun; 31(14):3130-46. PubMed ID: 22669466
[TBL] [Abstract][Full Text] [Related]
22. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
23. Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming.
Li R; Cauchy P; Ramamoorthy S; Boller S; Chavez L; Grosschedl R
Genes Dev; 2018 Jan; 32(2):96-111. PubMed ID: 29440261
[TBL] [Abstract][Full Text] [Related]
24. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells.
Ebert A; McManus S; Tagoh H; Medvedovic J; Salvagiotto G; Novatchkova M; Tamir I; Sommer A; Jaritz M; Busslinger M
Immunity; 2011 Feb; 34(2):175-87. PubMed ID: 21349430
[TBL] [Abstract][Full Text] [Related]
25. B Lymphocyte Specification Is Preceded by Extensive Epigenetic Priming in Multipotent Progenitors.
Strid T; Okuyama K; Tingvall-Gustafsson J; Kuruvilla J; Jensen CT; Lang S; Prasad M; Somasundaram R; Åhsberg J; Cristobal S; Soneji S; Ungerbäck J; Sigvardsson M
J Immunol; 2021 Jun; 206(11):2700-2713. PubMed ID: 34021049
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
Isidro-Hernández M; Mayado A; Casado-García A; Martínez-Cano J; Palmi C; Fazio G; Orfao A; Ribera J; Ribera JM; Zamora L; Raboso-Gallego J; Blanco O; Alonso-López D; De Las Rivas J; Jiménez R; García Criado FJ; García Cenador MB; Ramírez-Orellana M; Cazzaniga G; Cobaleda C; Vicente-Dueñas C; Sánchez-García I
Sci Rep; 2020 Nov; 10(1):19189. PubMed ID: 33154497
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
[TBL] [Abstract][Full Text] [Related]
28. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
[TBL] [Abstract][Full Text] [Related]
29. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.
Zandi S; Mansson R; Tsapogas P; Zetterblad J; Bryder D; Sigvardsson M
J Immunol; 2008 Sep; 181(5):3364-72. PubMed ID: 18714008
[TBL] [Abstract][Full Text] [Related]
30. PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.
Shang Z; Zhao Y; Zhou K; Xu Y; Huang W
Int J Hematol; 2013 May; 97(5):599-603. PubMed ID: 23529845
[TBL] [Abstract][Full Text] [Related]
31. Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.
Smeenk L; Fischer M; Jurado S; Jaritz M; Azaryan A; Werner B; Roth M; Zuber J; Stanulla M; den Boer ML; Mullighan CG; Strehl S; Busslinger M
EMBO J; 2017 Mar; 36(6):718-735. PubMed ID: 28219927
[TBL] [Abstract][Full Text] [Related]
32. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
[TBL] [Abstract][Full Text] [Related]
34. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.
Treiber T; Mandel EM; Pott S; Györy I; Firner S; Liu ET; Grosschedl R
Immunity; 2010 May; 32(5):714-25. PubMed ID: 20451411
[TBL] [Abstract][Full Text] [Related]
35. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
[TBL] [Abstract][Full Text] [Related]
36. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
[TBL] [Abstract][Full Text] [Related]
38. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
Fouad FM; Eid JI
Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
[TBL] [Abstract][Full Text] [Related]
39. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
40. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
